sanofi-aventis chief exec named chairman of PhRMA board
This article was originally published in SRA
Executive Summary
Christopher Viehbacher, the chief executive of sanofi-aventis, has taken over as chairman of the board of directors of US pharma industry association PhRMA. Mr Viehbacher replaces Jeffrey Kindler, who resigned as chairman and chief executive of Pfizer on 5 December.